Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation

Molecular Biology of the Cell

Volumn 22, Issue 1, 2011, Pages 105-116

  Abreu, Maria Teresa Herrera ^a   Hughes, William E ^a   Mele, Katarina ^a,b   Lyons, Ruth J ^a   Rickwood, Danny ^a   Browne, Brigid C ^a   Bennett, Haley L ^a   Vallotton, Pascal ^b   Brummer, Tilman ^a   Daly, Roger J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCKING PROTEIN; MUTANT PROTEIN; PHENYLALANINE; PROTEIN GAB 2; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VAV PROTEIN;

ARTICLE; BINDING SITE; BREAST EPITHELIUM; CANCER GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL SPREADING; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSKELETON; FOCAL ADHESION; GENE SILENCING; HUMAN; HUMAN CELL; MESENCHYME CELL; NEGATIVE FEEDBACK; ORGANIZATIONAL STRUCTURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS FIBER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; EPITHELIAL CELLS; FEMALE; FOCAL ADHESIONS; GENE EXPRESSION; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, FLUORESCENCE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS C-VAV; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; STRESS FIBERS;

EID: 78651109297     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-03-0185     Document Type: Article

References (55)

1. Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, Campbell SL, Burridge K, Der CJ (2000). Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 275, 10141-10149.
2. Arthur WT, Burridge K (2001). RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12, 2711-2720.
3. Barberis D, Casazza A, Sordella R, Corso S, Artigiani S, Settleman J, Comoglio PM, Tamagnone L (2005). p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling. J Cell Sci 118, 4689-4700. (Pubitemid 41646379)
4. Bennett HL, Brummer T, Jeanes A, Yap AS, Daly RJ (2008). Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis. Oncogene 27, 2693-2704.
5. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, Harris LN, Richardson A, Neel BG, Gu H (2006). A role for the scaffolding adapter GAB2 in breast cancer. Nature Med 12, 114-121.
6. Bocanegra M et al. (2010). Focal amplifi cation and oncogene dependency of GAB2 in breast cancer. Oncogene 29, 774-779.
7. Bos JL, Rehmann H, Wittinghofer A (2007). GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865-877.
8. Bradley WD, Hernandez SE, Settleman J, Koleske AJ (2006). Integrin signaling through Arg activates p190RhoGAP by promoting its binding to p120RasGAP and recruitment to the membrane. Mol Biol Cell 17, 4827-4836. (Pubitemid 44665751)
9. Brummer T et al. (2008). Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J 27, 2305-2316.
10. Brummer T, Schramek D, Hayes VM, Bennett HL, Caldon CE, Musgrove EA, Daly RJ (2006). Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. J Biol Chem 281, 626-637.
11. Chang Y, Ceacareanu B, Dixit M, Sreejayan N, Hassid A (2002). Nitric oxide-induced motility in aortic smooth muscle cells: role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho. Circulation Res 91, 390-397. (Pubitemid 35034206)
12. Chernoff KA et al. (2009). GAB2 amplifi cations refi ne molecular classifi cation of melanoma. Clin Cancer Res 15, 4288-4291.
13. Daly RJ, Gu H, Parmar J, Malaney S, Lyons RJ, Kairouz R, Head DR, Henshall SM, Neel BG, Sutherland RL (2002). The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21, 5175-5181.
14. Defilippi P, Di Stefano P, Cabodi S (2006). p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16, 257-263.
15. Duan L et al. (2010). Distinct roles for Rho versus Rac/Cdc42 GTPases down-stream of Vav2 in regulating mammary epithelial acinar architecture. J Biol Chem 285, 1555-1568.
16. Edlund S, Landstrom M, Heldin CH, Aspenstrom P (2002). Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13, 902-914.
17. Ellenbroek SI, Collard JG (2007). Rho GTPases: functions and association with cancer. Clin Exp Metastasis 24, 657-672.
18. Fincham VJ, Chudleigh A, Frame MC (1999). Regulation of p190 Rho-GAP by v-Src is linked to cytoskeletal disruption during transformation. J Cell Sci 112 (Pt 6), 947-956.
19. Heasman SJ, Ridley AJ (2008). Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nature Rev Mol Cell Biol 9, 690-701.
20. Herrera Abreu MT, Wang Q, Vachon E, Suzuki T, Chow CW, Wang Y, Hong O, Villar J, McCulloch CA, Downey GP (2006). Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fi broblasts through focal adhesions. J Cell Physiol 207, 132-143.
21. Horst B et al. (2009). Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol 174, 1524-1533.
22. Inagaki K, Noguchi T, Matozaki T, Horikawa T, Fukunaga K, Tsuda M, Ichihashi M, Kasuga M (2000). Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant. Oncogene 19, 75-84. (Pubitemid 30066353)
23. Janes PW, Daly RJ, deFazio A, Sutherland RL (1994). Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9, 3601-3608.
24. Kallin A, Demoulin JB, Nishida K, Hirano T, Ronnstrand L, Heldin CH, (2004). Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J Biol Chem 279, 17897-17904.
25. Ke Y, Wu D, Princen F, Nguyen T, Pang Y, Lesperance J, Muller WJ, Oshima RG, Feng GS (2007). Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene 26, 4951-4960.
26. Kodama A, Matozaki T, Fukuhara A, Kikyo M, Ichihashi M, Takai Y (2000). Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell 11, 2565-2575.
27. Kolsch V, Charest PG, Firtel RA (2008). The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci 121, 551-559.
28. Lee SH, Jeong EG, Nam SW, Lee JY, Yoo NJ, Lee SH (2007). Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology 39, 326-329.
29. Lim Y et al. (2008). PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol 180, 187-203.
30. Lynch DK, Daly RJ (2002). PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J 21, 72-82.
31. Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ, Park M (2000). The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20, 8513-8525.
32. Meng S, Chen Z, Munoz-Antonia T, Wu J (2005). Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. Biochem J 391, 143-151.
33. Oh ES, Gu H, Saxton TM, Timms JF, Hausdorff S, Frevert EU, Kahn BB, Pawson T, Neel BG, Thomas SM (1999). Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol Cell Biol 19, 3205-3215. (Pubitemid 29144565)
34. Omelchenko T, Vasiliev JM, Gelfand IM, Feder HH, Bonder EM (2003). Rho-dependent formation of epithelial "leader" cells during wound healing. Proc Natl Acad Sci USA 100, 10788-10793.
35. Pullikuth AK, Catling AD (2010). Extracellular signal-regulated kinase promotes Rho-dependent focal adhesion formation by suppressing p190A RhoGAP. Mol Cell Biol 30, 3233-3248.
36. Samayawardhena LA, Pallen CJ (2008). Protein-tyrosine phosphatase α regulates stem cell factor-dependent c-Kit activation and migration of mast cells. J Biol Chem 283, 29175-29185.
37. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523.
38. Sattler M et al. ( 2002). Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1, 479-492.
39. Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B, Birchmeier W (2000). Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol 149, 1419-1432.
40. Schoenwaelder SM, Petch LA, Williamson D, Shen R, Feng GS, Burridge K (2000). The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Curr Biol 10, 1523-1526.
41. Simpson KJ, Dugan AS, Mercurio AM (2004). Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64, 8694-8701.
42. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS (2008). Identifi cation of genes that regulate epithelial cell migration using an siRNA screening approach. Nature Cell Biol 10, 1027-1038.
43. Tomar A, Lim ST, Lim Y, Schlaepfer DD (2009). A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J Cell Sci 122, 1852-1862.
44. Vallotton P, Lagerstrom R, Sun C, Buckley M, Wang D, De Silva M, Tan SS, Gunnersen JM (2007). Automated analysis of neurite branching in cultured cortical neurons using HCA-Vision. Cytometry A 71, 889-895.
45. Vallotton P, Small JV (2009). Shifting views on the leading role of the lamellipodium in cell migration: speckle tracking revisited. J Cell Sci 122, 1955-1958.
46. Vila de Muga S et al. (2009). Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 28, 363-377.
47. von Wichert G, Haimovich B, Feng GS, Sheetz MP (2003). Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2. EMBO J 22, 5023-5035.
48. Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T (2004). Peroxisome proliferator-activated receptor γ ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res 95, e45-55.
49. Wohrle FU, Daly RJ, Brummer T (2009). Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 7, 22 .
50. Wu D, Pang Y, Ke Y, Yu J, He Z, Tautz L, Mustelin T, Ding S, Huang Z, Feng GS (2009). A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by Shp2 tyrosine phosphatase. PLoS One 4, e4914 .
51. Yamada S, Nelson WJ (2007). Localized zones of Rho and Rac activities drive initiation and expansion of epithelial cell-cell adhesion. J Cell Biol 178, 517-527.
52. Yu DH, Qu CK, Henegariu O, Lu X, Feng GS (1998). Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 273, 21125-21131. (Pubitemid 28385400)
53. Yu M, Luo J, Yang W, Wang Y, Mizuki M, Kanakura Y, Besmer P, Neel BG, Gu H (2006). The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 281, 28615-28626.
54. Yu WM, Hawley TS, Hawley RG, Qu CK (2002). Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration. Blood 99, 2351-2359.
55. Zatkova A, Schoch C, Speleman F, Poppe B, Mannhalter C, Fonatsch C, Wimmer K (2006). GAB2 is a novel target of 11q amplifi cation in AML/ MDS. Genes Chromosomes Cancer 45, 798-807.